Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 27, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Commercial Availability of Vyleesi™ (Bremelanotide Injection)

The First FDA-Approved As-Needed Treatment for Premenopausal Women Experiencing Low Sexual Desire and Associated Distress Now Available to Patients WALTHAM, Mass., Aug. 27, 2019 (GLOBE NEWSWIRE)...
August 20, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

WALTHAM, Mass., Aug. 20, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a new employee of (i) an...
August 13, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG PHARMACEUTICALS ANNOUNCES GRANT OF INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(c)(4)

WALTHAM, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a new employee of (i) an...
August 07, 2019 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update

Promoted products achieved sequential and year-over-year revenue and market share growth 2019 financial guidance lowered: exiting Makena intramuscular market and...
July 29, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, August 7, 2019 at 8:00 a.m. ET

WALTHAM, Mass., July 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2019 financial results will be released on Wednesday, August 7,...
June 21, 2019 17:23 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces FDA Approval of Vyleesi™ (Bremelanotide Injection) for Acquired, Generalized Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women

The First FDA-Approved As-Needed Treatment for Premenopausal Women Experiencing Distress or Interpersonal Difficulty Due to Low Sexual Desire 1 in 10 Premenopausal Women in the U.S....
May 29, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference

WALTHAM, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, president and chief executive officer, will present at the Jefferies...
May 17, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Host Analyst Day on May 22, 2019 in New York

WALTHAM, Mass., May 17, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it will host an Analyst Day for the investment community on Wednesday, May 22, 2019...
May 07, 2019 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update

Achieved record Feraheme revenue growth and more than 50% market share for Makena auto-injector Completed integration of Perosphere Pharmaceuticals Inc. and progressed ciraparantag clinical program...
May 03, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Presents New Data at the American College of Obstetricians and Gynecologists Annual Meeting

WALTHAM, Mass., May 03, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that it will present new data related to investigational drug bremelanotide for the...